The effects of once- versus twice-weekly sessions on psychotherapy outcomes in depressed patients by Bruijniks, Sanne J.E. et al.
VU Research Portal
The effects of once- versus twice-weekly sessions on psychotherapy outcomes in
depressed patients
Bruijniks, Sanne J.E.; Lemmens, Lotte H.J.M.; Hollon, Steven D.; Peeters, Frenk P.M.L.;
Cuijpers, Pim; Arntz, Arnoud; DIngemanse, Pieter; Willems, Linda; Van Oppen, Patricia;
Twisk, Jos W.R.; Van Den Boogaard, Michael; Spijker, Jan; Bosmans, Judith; Huibers,
Marcus J.H.
published in
British Journal of Psychiatry
2020
DOI (link to publisher)
10.1192/bjp.2019.265
document version
Publisher's PDF, also known as Version of record
document license
Article 25fa Dutch Copyright Act
Link to publication in VU Research Portal
citation for published version (APA)
Bruijniks, S. J. E., Lemmens, L. H. J. M., Hollon, S. D., Peeters, F. P. M. L., Cuijpers, P., Arntz, A., DIngemanse,
P., Willems, L., Van Oppen, P., Twisk, J. W. R., Van Den Boogaard, M., Spijker, J., Bosmans, J., & Huibers, M.
J. H. (2020). The effects of once- versus twice-weekly sessions on psychotherapy outcomes in depressed
patients. British Journal of Psychiatry, 216(4), 222-230. https://doi.org/10.1192/bjp.2019.265
General rights
Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners
and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights.
            • Users may download and print one copy of any publication from the public portal for the purpose of private study or research.
            • You may not further distribute the material or use it for any profit-making activity or commercial gain
            • You may freely distribute the URL identifying the publication in the public portal ?
Take down policy
If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately
and investigate your claim.
E-mail address:
vuresearchportal.ub@vu.nl
Download date: 27. May. 2021
The effects of once- versus twice-weekly sessions
on psychotherapy outcomes in depressed patients
Sanne J. E. Bruijniks, Lotte H. J. M. Lemmens, Steven D. Hollon, Frenk P. M. L. Peeters, Pim Cuijpers,
Arnoud Arntz, Pieter Dingemanse, Linda Willems, Patricia van Oppen, Jos W. R. Twisk,
Michael van den Boogaard, Jan Spijker, Judith Bosmans and Marcus J. H. Huibers
Background
It is unclear what session frequency is most effective in
cognitive–behavioural therapy (CBT) and interpersonal
psychotherapy (IPT) for depression.
Aims
Compare the effects of once weekly and twice weekly sessions
of CBT and IPT for depression.
Method
We conducted a multicentre randomised trial from November
2014 through December 2017. We recruited 200 adults with
depression across nine specialised mental health centres in the
Netherlands. This study used a 2 × 2 factorial design, randomis-
ing patients to once or twice weekly sessions of CBT or IPT over
16–24 weeks, up to a maximum of 20 sessions. Main outcome
measures were depression severity, measured with the Beck
Depression Inventory-II at baseline, before session 1, and
2 weeks, 1, 2, 3, 4, 5 and 6 months after start of the intervention.
Intention-to-treat analyses were conducted.
Results
Compared with patients who received weekly sessions, patients
who received twice weekly sessions showed a statistically
significant decrease in depressive symptoms (estimated mean
difference between weekly and twice weekly sessions at month
6: 3.85 points, difference in effect size d = 0.55), lower attrition
rates (n = 16 compared with n = 32) and an increased rate of
response (hazard ratio 1.48, 95% CI 1.00–2.18).
Conclusions
In clinical practice settings, delivery of twice weekly sessions of





Depressive disorders; cognitive–behavioural therapies; individ-
ual psychotherapy; randomised controlled trial; out-patient
treatment.
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Randomised trials on the effects of different psychotherapy formats
showed that a more intense dose of treatment can lead to a faster
response, less drop-out and better or non-inferior outcomes compared
with less-intense treatments.1–4 In the field of depression, a meta-
regression analysis showed that the number of sessions per week,
and not the total number of sessions or duration of therapy, was cor-
related with outcome.5 In an observational study, a higher session fre-
quency was associated with improvement and recoverywithin the first
three months of treatment.6 However, a randomised trial on the direct
effect of psychotherapy session frequency on depression is lacking.
The original Beck manual for cognitive–behavioural therapy (CBT)
for depression7 prescribes that CBT should start twice weekly in the
beginning of treatment, whereas interpersonal psychotherapy (IPT)
should be delivered once a week, according to Klerman’s manual.8
In both treatments, however, a higher session frequency might lead
to better depressive outcomes. Our hypothesis is that a higher
session frequency leads to better recall of the content of the sessions,
which will lead to a better development of therapy-specific skills
and consequently better treatment outcomes.9 An alternative hypoth-
esis is that a higher session frequency leads to a better working alliance,
which then leads to better patient adherence andmotivation, and con-
sequently better treatment outcomes.
This is the first randomised trial to investigate the effects of once
weekly versus twice weekly sessions of CBT and IPT for depression.
The primary hypothesis was that twice weekly sessions in the first 16
sessions of treatment leads to greater reduction of depressive symp-
toms and other outcomes in the acute phase of treatment. We also
assessed the effects on attrition and time to response, and potential
differences between CBT and IPT session frequency.
Method
Trial design
This study was registered with the Netherlands Trial Register (regis-
tration number NTR4856). Details about the study design have been
described elsewhere.9 Data are from amulticentre, randomised con-
trolled trial (2 × 2 factorial design) on the effects of session fre-
quency in CBT and IPT for depression, with a 24-month follow-
up. Patients were randomly assigned to four conditions: 16 sessions
of CBT twice a week, 16 weekly sessions of CBT, 16 sessions of IPT
twice a week and 16 weekly sessions of IPT. In each condition, the
16th session was followed by four biweekly sessions. Data presented
here concern post-treatment outcomes 6 months after the start of
treatment; follow-up data will be reported in a subsequent report.
Clinical outcomes on the long-term effects (Longitudinal
Interview Follow-up Evaluation) and cost-effectiveness (quality
of life, EuroQol-5D and the Trimbos and Institute for Medical
Technology Assessment Questionnaire on Costs associated with
Psychiatric Illness) outcomes will be reported in follow-up papers.
Participants and recruitment
Patients were adult out-patients referred to one of nine Dutch spe-
cialised mental healthcare centres located across the Netherlands.
Inclusion criteria were as follows: (a) a primary diagnosis of a
DSM-IV or DSM-5 major depressive disorder (including chronic
depression) or DSM-5 persistent depressive disorder as confirmed
by the Structured Clinical Interview for DSM-IV Axis I Disorders10
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or the Mini International Neuropsychiatric Interview Plus11,
(b) aged 18 to <65 years, (c) sufficient knowledge of the Dutch lan-
guage, (d) pre-treatment score ≥20 on the Beck Depression
Inventory-II (BDI-II)12 and (e) access to internet facilities (because
some of the assessments were online). Exclusion criteria were as
follows: (a) starting antidepressants or dosage change in the past 3
months, (b) acute suicide risk, (c) DSM-IV or DSM-5 diagnosis of
drug or alcohol dependence, (d) presence of a DSM-IV or DSM-5
diagnosis of a cluster A or B personality disorder as evaluated by a
clinician during the intake with or without help of a structured inter-
view and (e) receivedmore than five sessions of adequate CBT or IPT
in the previous year (clinician-evaluated at intake).
Procedure
Patients were recruited during regular intakes at the clinical sites.
Eligible patients were approached for participation in the study
and received a general information folder. A week after the
intake, an independent research assistant contacted eligible
patients to give them additional study information and to check
whether the patient was motivated to participate in the study.
Subsequently, patients were invited for a diagnostic interview (if
not completed during intake), an online baseline assessment and
signing of informed consent. Informed consent for videotaping
the sessions was signed separately; patients who were included in
the trial were allowed to refuse videotaping of their therapy sessions.
After the baseline assessment, block randomisation took place.
Randomisation codes were generated by an independent computer
scientist to ensure allocation concealment. Patients were rando-
mised into one of the four conditions, using a computer script (allo-
cation ratio: 1:1:1:1). Randomisation was stratified according to
severity (high, BDI-II score ≥29; low, BDI-II score ≤28) and treat-
ment site, using different blocks for high versus low severity and
each treatment site. After baseline, online assessments were con-
ducted 2 weeks after the start of treatment and every month until
month 6. In addition, participants filled out the BDI-II and single
questions on mood and happiness online in the therapist’s office
before the start of each therapy session. Post-treatment effect size
for the difference in depressive symptoms between the session fre-
quencies was estimated to be around 0.45.5 Therefore, 200 patients
were needed for adequate power (alpha = 0.05, power (1−ß) = 0.80,
two-tailed) to detect a difference between session frequencies, taking
25% drop-out into account.
Interventions
Treatment manuals were used for both interventions regardless of
frequency and both treatments consisted of a minimum of 12 and
maximum of 20 45-minute face-to-face sessions, depending on
patient progress. CBT was based on the manual by Beck et al7
and IPT was based on the manual by Klerman et al.8 Except for
the structuring of session frequency, no changes were made to the
original treatment manuals after the seeking advice from various
CBT and IPT experts. Participants who were randomised to the
condition with twice weekly sessions received 16 sessions during
the first 8 weeks of treatment, and 4 sessions during the last 8
weeks (up to 20 sessions over a period of 16 weeks). Patients who
were randomised to the condition with once weekly sessions
received 16 sessions during the first 16 weeks and 4 sessions
during the last 8 weeks (up to 20 sessions over a period of 24 weeks).
Treatment integrity
Before the study, therapists received 2 days of training by S.D.H.
(CBT) or Dr Holly Swartz (IPT). During the study, therapists
received supervision and consulted each other on current cases in
on-site consultation sessions. The format and the amount and fre-
quency of supervision and consultation sessions differed per
centre and therapist, varying from 30 min to 2 h biweekly (i.e. in
most centres, these meetings also included discussion of patients
that did not participate in the study). Therapists that were still
in postgraduate clinical training received additional weekly to
monthly supervision from an experienced supervisor in the
context of the study. Therapists that entered the study after the
training received additional training and elaborate instructions
about the study and protocol. To prevent contamination, therapists
were uniquely assigned to one of the treatment conditions.
However, because of problems with capacity, 7 therapists treated
37 patients in both conditions.
The modified version of the Collaborative Study Psychotherapy
Rating Scale version 6 (CSPRS-613,14) was used as a measure
of adherence (i.e. whether the therapy protocol was followed).
Treatment adherence was measured by independent expert raters
(3 psychotherapists and 1 psychologist) that assessed 51 randomly
selected videos of different patients drawn between sessions 6 and
12. To examine therapy competence (i.e. how well the therapy
was performed), master-level clinical graduate students rated a
total of 116 unique CBT videos and 131 unique IPT videos. Total
scores on the Cognitive Therapy Scale15 (CTS; range 11–77), the
IPT Adherence and Quality Scale (short version)16 (IPT-AQS;
range 9–125) and the score on the single item ‘How would you
rate the clinician overall in this session, as a CBT/IPT therapist?’
measured on a Likert scale ranging from 1 (poor) to 7 (excellent)
were used. Details about treatment integrity can be found in Data
Supplement 1 available at https://doi.org/10.1192/bjp.2019.265.
Primary outcomes
Primary outcome was depression severity as measured with the
BDI-II.12 The BDI-II is a 21-item self-report instrument assessing
depressive symptoms over the past 2 weeks. A score of 0–13
indicated minimal depression, 14–19 indicated mild depression,
20–28 indicated moderate depression and 29–63 indicated severe
depression. Reliability and validity of the BDI-II has been previously
reported.17
Secondary outcomes
Secondary outcomes included a single item rating of ‘current mood’
(0, ‘worst mood ever’ to 100, ‘best mood ever’); two single items
rating happiness, ‘general life happiness’ and ‘happiness today’
(1, ‘completely unhappy’ to 7, ‘completely happy’); the general
health perception domain of the RAND 36-Item Health
Survey (RAND-36);18,19 and the Remission of Depression
Questionnaire20 (RDQ). The RDQ measures remission as a broad
construct including reduction in depressive symptoms and other
depression-related domains, with lower scores representing better
functioning on each subscale. The RDQ and RAND-36 were
measured at baseline and at 3 and 6 months after the start of treat-
ment. The mood and happiness questions were both included
before each session and in the online assessments. For a detailed
description of these instruments and their psychometric properties,
we refer to our protocol paper.9
Data analyses
The flow chart, pre-treatment variables, treatment and study adher-
ence, therapists characteristics and treatment integrity were
described in the result section. Differences in days between sessions
between frequency conditions were tested with univariate analysis
of variance. Differences in attrition between session frequencies
were tested with a χ2 test.
Psychotherapy session frequency and outcomes
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Multilevel regression analyses with maximum likelihood esti-
mation were conducted to investigate the effect of frequency condi-
tion on depression (BDI-II scores). Intervention was represented by
two dichotomous variables: CBT (−1) versus IPT (1) and once
weekly (−1) versus twice weekly (1) sessions. Because of the long
waiting time (mean 35.20 days, s.d. 27.05) between baseline and
session 1 (see also Data Supplement 3), we decided to add the
BDI-II score measured at the start of session 1 to the outcome
(i.e. dependent variable was BDI-II score measured before session
1, and 2 weeks and monthly after start of treatment up to month
6, leading to a total of eight time points). The model corrected for
baseline values by adding BDI-II baseline as a covariate in the
model.21 The initial basic model was a two-level model with
repeated measurements (level 1) nested within patients (level 2)
with two two-way interactions testing the difference in change of
BDI-II scores over time in days for the different session frequencies
(time×frequency) and treatments (time×treatment). Time in days
was centred 90 days after the start of treatment and it was tested
whether a quadratic or cubic function of time led to better model
fit. Subsequently, the addition of random levels on therapist and
treatment centre were tested, followed by a test of random slopes
for time on all fitted random levels. Fit of different (co)variance
structures for both the random effects and residuals errors within
the lowest level (repeated measurements) were compared. To
explore whether the effect of session frequency was different for
CBT versus IPT, a model with a three-way interaction (frequency
× treatment × time) was fitted. Analyses were intention to treat,
and significance levels were set at P < 0.05. The same method was
used to investigate effects on the secondary outcomes.
Effect sizes from session 1 to month 6 (Cohen’s d)22 for the
primary outcomes were computed: (estimated session 1mean – esti-
mated mean at time i) / estimated s.d. at session 1). Response (reli-
able change) was defined as a decrease of at least 9 BDI-II points
from session 1 to month 6 and remission (clinically significant
change) as an absolute value ≤9 on the BDI-II at month 6. Cox
regression was conducted to examine differences in the time in
days to response and remission for weekly versus twice weekly ses-
sions, including treatment modality and the BDI-II baseline score as
covariates.
Three sensitivity analyses were conducted. First, it was investi-
gated whether the total number of sessions, the presence of a
comorbid anxiety disorder or the use of antidepressants were cov-
ariates that influenced the main results. Second, because a
number of the time points (week 2, month 1, month 2, month 3
andmonth 4) are not comparing the same number of treatment ses-
sions between frequency conditions and this could potentially skew
the estimates in the analysis, we additionally tested the change in
BDI-II scores from baseline to month 6, ignoring symptom levels
across the other time points. Third, a completers analysis was con-
ducted, reporting estimated difference in BDI-II scores at month 6
and the difference in effect size between frequency conditions. Non-
completers were defined as patients who discontinued therapy,
deviated to other protocols or changed antidepressant use before
session 12. All other patients were considered completers.
Results are reported according to the Consolidated Standards Of
Reporting Trials guidelines.23 For more details about the data ana-
lyses we refer to Data Supplement 2.
Ethics statement
The authors assert that all procedures contributing to this work
comply with the ethical standards of the relevant national and insti-
tutional committees on human experimentation and with the
Helsinki Declaration of 1975, as revised in 2008. All procedures
involving human patients were approved by the Medical Ethical
Committee of VU Medical Centre Amsterdam (registration
number 2014.337).
Results
Description of the sample
The flow of patients is shown in Fig. 1. A total of 3179 patients were
initially screened for eligibility, of whom 2380 did not meet the
inclusion criteria and 235 patients met the inclusion criteria but
declined to participate. This resulted in a total sample of 200
patients (CBT weekly, n = 49; CBT twice weekly, n = 49; IPT
weekly, n = 55, IPT twice weekly, n = 47).
Mean age at baseline was 37.85 years (s.d. 12.26) and 61.5% of
participants were female. Mean baseline BDI-II score was 34.70
(s.d. 9.96), 43.3% of the sample experienced recurrent depression
and self-reported duration of symptoms was 40.87 months (s.d.
68.31; median 20). The majority (68%) of the total sample was
still actively employed. Pre-treatment characteristics per condition
are presented in Table 1. Observedmeans (s.d.) on all outcomemea-
sures at each time point for each condition are given in Table 2.
Treatment and study adherence
Recruitment took place from November 2014 to January 2018. The
patients that started treatment (n = 191) received a mean number of
16.54 (s.d. 4.73) sessions. There was a significant difference in days
between the sessions and treatment duration between patients who
received the weekly (mean 8.98 days, s.d. 3.06; mean 170 days, s.d.
67.23) versus the twice weekly (mean 4.68 days, s.d. 2.28;
mean 113 days, s.d. 43.62) frequency condition (t(177) = 10.92,
P = <.001 and t(165.68) = 6.98, P = <0.001 for session frequency
and treatment duration, respectively). There was no difference
between frequency conditions in the total number of sessions. Of
the 48 patients that were registered as non-completers, 14 withdrew
or were lost to follow-up, 9 never started with treatment, 20
switched to another intervention or started or switched antidepres-
sants before the 12th session, 2 received a session frequency differ-
ent from the one to which they were randomised and 3 could not
complete treatment because of a lack of therapists at the treatment
centre. Four patients who completed treatment before session 12
were considered to be completers because their therapist indicated
that therapy was successful. More patients dropped out of weekly
(n = 32) than twice weekly (n = 16) treatment (χ2 = 5.44, P = 0.02).
With regard to study adherence, the percentages of participants
completing assessments on each time point were 58% for week 2,
78.5% for month 1, 76.5% for month 2, 71.5% for month 3, 68%
for month 4, 65.5% for month 5 and 72.5% for month 6. Study
adherence was not different between frequency conditions, except
for month 3, in which there were more missing data in the weekly
condition (n = 37 compared with n = 20; χ2 = 5.32, P = 0.02).
Treatment characteristics per condition are given in Data
Supplement 3.
Therapists
The 76 therapists (25–61 years of age, 81.6% female) who
participated in the study were licensed mental health psychologists
(n = 38), master-level (MSc) psychologists in post-master training
(n = 32), psychiatrists (n = 2) and mental health nurses (n = 4).
Therapists had an average of 9.55 years (s.d. 8.29; n = 64) of clinical
experience (range 0.5–29 years). The number of patients per therap-
ist ranged from 1 to 12 (mean 2.67, mode 1). IPT therapists had
fewer years of experience with IPT than CBT therapists had with
CBT (IPT: mean 4.01, s.d. 6.50; CBT: mean 6.46, s.d. 6.13). There
were no significant differences in treatment outcome (t(143) =
Bruijniks et al
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Assessed for eligibility (n= 3179)
Excluded (n= 2978)
Not meeting inclusion criteria (n= 2380)
Declined to participate (n= 235)
Other reasons (n= 364)
CBT weekly (n= 49)
Received allocated
  intervention (n= 47) 
Did not start allocated
  intervention (n= 2;
  reasons: 2 started with
  another treatment unrelated




CBT twice weekly (n = 49)
Received allocated
   intervention (n= 48) 
Did not start allocated
   intervention (n= 1;
    reasons: 1 no therapist
    available)
IPT weekly (n = 55)
Received allocated
   intervention (n= 51) 
Did not start allocated
   intervention (n = 4; reasons: 
   2 felt better and did not want
   treatment anymore; 1 no
   therapist available; 1 did not
   want treatment anymore)
IPT twice weekly (n= 47)
Received allocated
   intervention (n= 45) 
Did not start allocated
   intervention (n = 2;
    reasons: 1 felt better and did
    not want treatment anymore;
   1 started another treatment)
Total lost to follow-up per time
point **
4 between baseline
and session 1; 2 did
not start treatment, 2 sessions




2; 10 were unattainable and did
not respond to requests, 12 did
not receive T2
9 between week 2
and month 1; 8 were
unattainable and did not respond
to requests, 1 no longer wanted
to participate    
10 between month
1 and month 2; 8
were unattainable and did not
respond to requests, 2 no longer
wanted to participate
14 between month
2 and month 3; 12
were unattainable and did not
respond to requests, 2 no longer
wanted to participate
14 between month
3 and month 4; 12
were unattainable and did not
respond to requests, 2 no longer
wanted  to participate  
12 between month
4 and month 5; 10
were unattainable and did not
respond to requests 2 no longer
wanted to participate
12 between month
5 and month 6; 10
were unattainable and
did not respond to requests, 
2 no longer wanted to participate
Total lost to follow-up per time
point **
1 between baseline
and session 1; 1 did not start
treatment   
16 between
baseline and week
2; reasons: 8 were
unattainable and did not respond
to requests, 8 did not receive T2
14 between week 2
and month 1; 14 were
unattainable and did not respond
to requests
11 between month
1 and month 2; 9
were unattainable and did not
respond to requests, 2 no longer
wanted to participate
12 between month
2 and month 3; 10
were unattainable and did not
respond to requests, 2 no longer
wanted to participate
12 between month
3 and month 4; 10
were unattainable and did not
respond to requests, 2 no longer  
wanted to participate
19 between month
4 and month 5; 17
were unattainable and did not
respond to requests, 2 no longer
wanted to participate
14 between month
5 and month 6; 12 were
unattainable and did not respond
to requests, 2 no longer wanted
to participate
Total lost to follow-up per time 
point **
6 between baseline
and session 1; 4 did not start





2; reasons: 12 were
unattainable and did not respond
to requests, 12 did not receive T2, 
2 no longer wanted to participate
14 between week 2
and month 1; 10 were
unattainable and did not respond
to requests, 4 no longer wanted
to participate
19 between month
1 and month 2; 14
were unattainable and did not
respond to requests, 5 no longer
wanted to participater
22 between month
2 and month 3; 16
were unattainable and did not
respond to requests, 6 no longer
wanted to participate
23 between month
3 and month 4; 17
were unattainable and did not
respond to requests, 6 no longer
wanted to participate
25 between month
4 and month 5; 19
were unattainable and did not
respond to requests, 6 no longer
wanted to participate
21 between month
5 and month 6; 15
were unattainable and did not
respond to requests, 6 no longer
wanted to participate
Total lost to follow-up per time 
point **
5 between baseline
and session 1; 1 did not start 
treatment, 4 sessions where
questionnaires were not completed
20 between
baseline and week
2; reasons: 6 were unattainable
and did not respond to requests,
14 did not receive T2
6 between week 2
and month 1; 6 were unattainable  
7 between month 1
and month 2; 6 were unattainable
and did not respond to requests, 1
no longer wanted to participate    
9 between month 2
and month 3; 8 were unattainable
and did not respond to requests, 1   
no longer wanted to participate 
15 between month
3 and month 4; 14 were
unattainable and did not respond to
request, 1 no longer wanted to 
participate
13 between month
4 and month 5; 12 were
unattainable and did not respond to
requests, 1 no longer wanted to
participate
8 between month 5
and month 6; 7 were
unattainable and did not respond to 





Excluded from analysis 
(n= 0)
Analysed (n=55)
Excluded from analysis 
(n = 0)
Analysed (n= 47)
Excluded from analysis 
(n= 0)
Analysed (n=49)
Excluded from analysis 
Discontinued intervention
*** (n=11, reasons: 4 withdrew; 
6 switched to another intervention or 
started or changed antidepressants; 1
received another session frequency 
condition)    
Discontinued intervention
*** (n=6, reasons: 2 withdrew;
3 switched to another intervention or
started or changed antidepressants; 1




withdrew; 6 switched to another 
intervention or started or changed
antidepressants; 2 did not start because
there was no therapist available)   
Discontinued intervention
*** (n=7,switched to another or
started or changed antidepressants; 1
could not continue because there was
no therapist available)
(n= 0)
Fig. 1 Patient flow chart.
Note that ‘lost to follow-up’** presents study adherence and ‘discontinued intervention’*** treatment adherence. Numbers on study adherence are based on the presence of the
Beck Depression Inventory-II scores per time point. Of the 235 patients who met the inclusion criteria but declined to participate, 30 patients explicitly declined to participate
because they did not want to receive therapy in a higher session frequency and 43 patients explicitly declined to participate because they preferred CBT, IPT or another treatment
(e.g. antidepressants). The remaining 162 patients declined because they did not want the extra investment of completing research questionnaires (n = 21), or for unknown reasons
(n = 141); 364 patients were excluded for ‘other reasons’, such as participation in another study, assignment to another treatment or because the reason for exclusion was unclear.
Note that 3179 (screened) – 2978 (declined) = 201, but that one participant asked for complete deletion of his/her data and was therefore not included in the flow chart.
CBT, cognitive–behavioural therapy; IPT, interpersonal psychotherapy.
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1.19, P = 0.23) or attrition (t(198) = 0.79, P = 0.42) between patients
that were treated by single versus multiple modality therapists.
Treatment integrity
A total of 1771 videos of 129 patients were available. CBT-specific
behaviour (adherence) as rated with the CSPRS-6 was significantly
more evident in CBT than in IPT (CBT: mean 89.92, s.d. 33.84,
n = 27 versus IPT: mean 57.56, s.d. 10.19, n = 23, t(31.41) = 4.72,
P < 0.001). IPT-specific behaviour as rated with the CSPRS-6 was
more present in IPT than in CBT (IPT: mean 95.50, s.d. 20.26,
n = 24 versus CBT: mean 32.59, s.d. 5.38, n = 27; t(25.88) =
−14.75, P < 0.001). CBT competence as rated with the CTS varied
from poor to very good (Likert scale: mean 3.69, s.d. 1.08, n = 61;
CTS total: mean 45.55, s.d. 9.82, n = 60), and 16.3% of the CBT ses-
sions were rated good to excellent. IPT competence as rated with the
IPT-AQS varied from poor to very good (Likert scale: mean 3.64,
s.d. 1.27, n = 66; IPT-AQS: mean 66.48, s.d. 14.02, n = 66) and
12.1% of the IPT sessions were rated good to excellent. There
were no differences in treatment adherence or treatment compe-
tence between the once weekly versus the twice weekly conditions.
Treatment outcomes
Effect of session frequency over time
Results show a significant effect of session frequency on BDI-II
scores over time in favour of twice weekly sessions (estimated
mean difference between weekly versus twice weekly sessions
at month 6: 3.85 points on the BDI-II, difference in effect size
d = 0.55; estimated mean scores: 31.05 (95% CI 29.29–32.81) to
23.01 (95% CI 19.45–26.57) for once weekly CBT; 32.58 (95%
CI 30.84–34.32) to 20.69 (95% CI 17.18–24.21) for twice
weekly CBT; 32.49 (95% CI 30.77–34.21) to 24.30 (95% CI
20.77–27.83) for once weekly IPT; and 34.02 (95% CI 32.25–
35.79) to 21.98 (95% CI 18.44–25.52) for twice weekly IPT;
also see Data Supplement 4). There were no differences in
change over time on the BDI-II between CBT and IPT. There
was no different effect of session frequency in CBT versus IPT.
Change of BDI-II scores over time between conditions is given
in Fig. 2. Corrected mixed-model estimated means (95% confi-
dence intervals) on all outcome measures at each time point
for each condition are given in Data Supplement 4. The mixed
regression model on the BDI-II scores can be found in Data
Supplement 5. Within- and between-group effect sizes can be
found in Data Supplement 9.
Sensitivity and completers analyses
The total number of sessions, the presence of a comorbid anxiety
disorder or the use of antidepressants were not significant covariates
and did not influence the results. In addition, the effect of session
frequency remained significant when testing change in BDI-II
scores from baseline to month 6, without including the other time
points. In congruence with the intention-to-treat analyses, results
show a significant effect of session frequency on BDI-II scores
over time in favour of twice weekly sessions when running the ana-
lysis in completers only (n = 152; estimated BDI-II mean difference
between weekly versus twice weekly sessions at month 6, 3.80;
difference in effect size d = 0.53) and there were no differences in
change over time on the BDI-II between CBT and IPT.










Female gender, n (%) 33 (67.3) 29 (59.2) 33 (60) 28 (59.6)
Age in years, mean (s.d.) 35.69 (12.67) 40.67 (11.76) 36.81 (11.67) 38.38 (12.79)
Highest completed education, n (%)
Low 4 (8.2) 5 (10.2) 6 (10.9) 6 (12.8)
Medium 23 (46.9) 27 (55.1) 27 (49.1) 25 (53.2)
High 22 (44.9) 17 (34.7) 22 (40) 16 (34)
Partner, n (%) 17 (34.7) 17 (34.7) 16 (29.1) 22 (46.8)
Active employment, n (%) 33 (67.3) 35 (72.9) 37 (69.8) 29 (61.7)
Born in the Netherlands, n (%) 40 (81.6) 37 (75.5) 45 (81.8) 37 (78.7)
Both parents born in the Netherlands, n (%) 33 (67.3) 27 (55.1) 37 (67.3) 25 (53.2)
Experience of general health
RAND-36, mean (s.d.) 42.85 (21.33) 43.97 (17.55) 43.09 (17.28) 43.61 (18.04)
Depression specifiers
BDI-II baseline score, mean (s.d.) 36.02 (9.36) 35.65 (8.69) 33.36 (9.50) 33.91 (12.15)
First depressive episode, n (%) 30 (68.2) 18 (46.2) 25 (53.2) 24 (58.5)
Number of episodes (including current episode), mean (s.d.) 1.79 (1.71) 2.05 (1.29) 1.95 (1.26) 1.70 (1.03)
Severe depression, n (%) 36 (73.5) 39 (79.6) 36 (65.5) 31 (66)
Chronic depression, n (%) 23 (46.9) 24 (49) 25 (45.5) 21 (44.7)
Self-reported duration of symptoms in months, mean (s.d.) 39.85 (52.66) 50.40 (80.33) 39.47 (80.67) 33.63 (52.59)
Symptoms untenable in months, mean (s.d.) 12.61 (13.04) 13.44 (19.87) 17.67 (37.92) 13.54 (17.99)
Number of comorbid Axis I disorders, mean (s.d.) 1.06 (1.24) 0.91 (0.98) 1.19 (1.35) 0.93 (1.26)
Comorbid anxiety disorder, n (%) 23 (46.9) 22 (44.9) 29 (52.7) 19 (40.4)
Comorbid PTSD, n (%) 3 (6.5) 2 (4.1) 6 (11.3) 2 (4.7)
Comorbid other than anxiety, n (%) 3 (6.1) 6 (12.2) 8 (14.5) 7 (14.9)
Self-reported use of antidepressants at baseline, n (%) 14 (28.6) 11 (22.4) 13 (23.6) 15 (31.9)
Received individual psychotherapy before (self-report), n (%) 41 (83.7) 42 (85.7) 48 (87.3) 41 (87.2)
Note that severe depression is defined as a BDI-II score >28. Low educational level has been defined as no former education or special lower education or primary school or practical training
school; middle educational level has been defined as completing lower general secondary education or higher general secondary education or intermediate vocational education; and
higher education level has been defined as completing higher vocational education or pre-university education or university. Note that students were also considered as active employment.
The RAND-36 reports the total score of the subscale ‘general experience of health’, range of 5 (low perception of general health) to 25 (high perception of general health). Comorbid Axis I
disorders were established with use of theMINI-Plus or SCID-I. In case of missing data, the number of available data per condition is given. Data weremissing for first depressive episode and
number of episodes: CBT weekly (missing n = 5), CBT twice weekly (missing n = 10), IPT weekly (missing n = 8) and IPT twice weekly (missing n = 6); and for MINI-Plus or SCID-I: CBT weekly
(missing n = 5), CBT twiceweekly (missing n = 1), IPT weekly (missing n = 3) and IPT twiceweekly (missing n = 4). CBT, cognitive–behavioural therapy; IPT, interpersonal psychotherapy; RAND-
36, RAND 36-Item Health Survey; BDI-II, Beck Depression Inventory-II; PTSD, post-traumatic stress disorder; MINI-Plus, Mini International Neuropsychiatric Interview Plus; SCID-I, Structured
Clinical Interview for DSM-IV Axis I Disorders.
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Table 2 Observed mean scores (s.d.) for all outcome measures in the intention-to-treat sample stratified by condition
Observed means (s.d.)
CBT weekly (n = 49) CBT twice weekly (n = 49) IPT weekly (n = 55) IPT twice weekly (n = 47)
Primary outcome
Beck Depression Inventory-II
Baseline 36.02 (9.36) 35.65 (8.69) 33.36 (9.50) 33.91 (12.15)
Session 1 30.64 (10.33) 33.22 (9.42) 31.85 (10.92) 31.26 (11.47)
Week 2 28.11 (10.65) 33.51 (8.73) 33.13 (10.29) 31.77 (12.16)
Month 1 29.67 (11.76) 31.17 (11.77) 32.73 (10.57) 29.73 (13.51)
Month 2 29.05 (12.68) 27.15 (12.51) 28.27 (12.90) 26.05 (14.55)
Month 3 26.74 (13.67) 26.56 (11.92) 26.75 (11.20) 22.81 (14.18)
Month 4 23.17 (14.02) 25.51 (13.63) 24.81 (11.94) 22.53 (16.12)
Month 5 23.29 (14.72) 23.93 (14.79) 24.4 (14.19) 19.38 (15.22)
Month 6 24.16 (15.09) 21.25 (12.90) 22.91 (14.75) 20.02 (16.05)
Secondary outcomes
Current mood
Baseline 27.40 (18.65) 23.02 (19.29) 30.89 (21.34) 33.70 (20.82)
Session 1 41.48 (16.30) 31.68 (16.49) 34.26 (16.17) 37.73 (15.10)
Week 2 43.66 (18.34) 32.22 (14.14) 29.58 (16.69) 38.85 (20.52)
Month 1 41.65 (21.25) 37.51 (19.40) 37.85 (17.04) 41.48 (20.23)
Month 2 47.53 (20.98) 48.73 (16.77) 41.97 (20.16) 44.7 (21.95)
Month 3 45.91 (19.58) 48.29 (17.34) 46.91 (22.27) 51.58 (19.92)
Month 4 50.74 (21.83) 48.16 (21.11) 45.21 (18.33) 51.18 (21.16)
Month 5 50.02 (22.87) 51.44 (20.52) 48.06 (20.10) 54.45 (22.90)
Month 6 51.28 (23.24) 53.05 (18.68) 50.52 (22.92) 56.25 (23.11)
General life happiness
Baseline 2.85 (0.97) 2.71 (1.09) 2.89 (0.99) 3.06 (1.18)
Session 1 2.97 (0.81) 2.64 (0.93) 2.91 (1.13) 3.04 (1.05)
Week 2 3.25 (1.02) 3.05 (0.80) 3.06 (0.75) 3.55 (1.21)
Month 1 3.30 (1.06) 3.22 (1.03) 3.04 (0.90) 3.36 (1.17)
Month 2 3.28 (1.23) 3.71 (0.86) 3.58 (1.27) 3.72 (1.21)
Month 3 3.34 (1.23) 3.86 (1.03) 3.55 (1.10) 3.92 (1.13)
Month 4 3.74 (1.14) 3.91 (1.08) 3.62 (1.07) 3.93 (1.34)
Month 5 3.70 (1.26) 3.76 (1.10) 3.80 (1.24) 4.42 (1.06)
Month 6 3.63 (1.30) 4.17 (1.16) 3.88 (1.45) 4.23 (1.15)
Happiness today
Baseline 3.04 (1.01) 2.93 (0.89) 3.05 (1.20) 3.29 (1.08)
Session 1 3.51 (0.84) 3.16 (0.95) 3.22 (0.94) 3.40 (0.96)
Week 2 3.55 (0.89) 3.17 (0.85) 3.03 (0.77) 3.44 (1.15)
Month 1 3.42 (1.12) 3.34 (1.10) 3.09 (1.05) 3.39 (1.22)
Month 2 3.56 (1.25) 3.71 (1.01) 3.58 (1.36) 3.57 (1.21)
Month 3 3.68 (1.20) 3.86 (0.94) 3.61 (1.15) 4.05 (1.19)
Month 4 3.97 (1.20) 3.78 (1.18) 3.59 (1.13) 4.03 (1.28)
Month 5 4 (1.35) 4.03 (1.03) 3.64 (1.27) 4.34 (1.21)
Month 6 3.68 (1.29) 4.33 (0.95) 3.77 (1.41) 4.33 (1.08)
Remission of Depression Questionnaire
Depressive symptoms
Baseline 15.83 (3.86) 15.44 (3.58) 15.4 (4.26) 15.38 (4.52)
Month 3 12.91 (5.62) 12.81 (5.41) 13.38 (4.49) 12.51 (6.14)
Month 6 11.75 (6.87) 10.48 (6.09) 12.02 (6.06) 9.92 (6.78)
Other symptoms often present in depressed patients, such as anxiety and irritability
Baseline 6.68 (2.44) 6.81 (1.83) 6.41 (2.43) 6.44 (1.87)
Month 3 5.17 (3.14) 5.51 (2.98) 6.05 (2.39) 5.35 (3.16)
Month 6 4.97 (3.59) 4.2 (2.78) 5.26 (2.97) 4.46 (3.43)
Coping ability
Baseline 4.29 (1.42) 4.28 (1.45) 4.10 (1.61) 4.25 (1.59)
Month 3 3.14 (1.95) 3.45 (1.82) 3.5 (1.52) 2.91 (2.07)
Month 6 3.64 (1.95) 2.68 (1.89) 3.05 (1.92) 2.43 (2.00)
Positive health
Baseline 17.33 (3.59) 17.48 (3.34) 17 (4.10) 16.48 (4.00)
Month 3 14.77 (5.32) 14.18 (6.51) 14.05 (4.84) 12.18 (5.96)
Month 6 13.51 (6.51) 11.37 (6.57) 12.47 (6.53) 9.74 (6.74)
Functioning
Baseline 3.70 (1.72) 3.93 (1.32) 3.98 (1.56) 3.53 (1.53)
Month 3 2.85 (1.89) 3.13 (1.89) 3.17 (1.69) 2.44 (1.86)
Month 6 2.94 (2.01) 2.57 (1.89) 2.94 (1.81) 2.23 (2.12)
Life satisfaction
Baseline 4.68 (1.27) 4.83 (1.23) 4.58 (1.47) 4.31 (1.46)
Month 3 3.82 (1.77) 3.83 (1.89) 3.45 (1.55) 3.21 (2.07)
Month 6 3.32 (2.13) 3.02 (1.60) 3.35 (1.87) 2.48 (2.12)
(Continued )
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Analysis of secondary outcome measures
There was a significant difference between session frequencies in
current mood, happiness in general and happiness today over
time in favour of twice weekly sessions (current mood estimated
mean difference at month 6, 3.98; happiness in general estimated
mean difference at month 6, 0.25; happiness today estimated
mean difference at month 6, 0.42). Results show trends toward sig-
nificance on the RAND-36 (in favour of the twice weekly sessions;
Table 2 (Continued )
Observed means (s.d.)
CBT weekly (n = 49) CBT twice weekly (n = 49) IPT weekly (n = 55) IPT twice weekly (n = 47)
General sense of well-being
Baseline 4.91 (1.16) 4.71 (1.42) 4.6 (1.40) 4.25 (1.46)
Month 3 4.17 (2.01) 3.78 (2.13) 3.73 (1.55) 3.16 (2.07)
Month 6 3.75 (2.19) 3.11 (2.07) 3.58 (1.92) 2.53 (2.25)
RAND-36, general health perception
Baseline 42.85 (21.33) 43.97 (17.55) 43.09 (17.28) 43.61 (18.04)
Week 2 51.34 (19.48) 44.11 (16.56) 40 (18.15) 43.88 (18.97)
Month 3 49.85 (21.53) 46.08 (21.11) 46.17 (14.46) 46.79 (20.23)
Month 6 50.13 (22.20) 51.53 (22.36) 46.80 (20.46) 53.46 (20.67)
Note that not all patients completed all measurements, total lost to follow-up per time point on the BDI-II scores can be found in Fig. 1. The RAND-36 reports the total score of the subscale
‘general experience of health’, range of 5 (low perception of general health) to 25 (high perception of general health). Note that for the RDQ, lower scores represent better functioning on each
subscale. Missing data on the secondary outcomes differed frommissing data on the BDI-II (also see flow chart) on the following time points (number of missing data is given): RAND-36 week
2, CBT weekly n = 23 and CBT twice weekly n = 15; RAND-36month 3, IPT weekly n = 21 and IPT twice weekly n = 8; RAND-36 month 6, CBT twice weekly n = 10 and IPT weekly n = 19; current
mood week 2, CBT twice weekly n = 14; current mood month 1, IPT weekly n = 13; current moodmonth 3, IPT weekly n = 21; current moodmonth 5, CBT twice weekly n = 20, IPT weekly n =
24 and IPT twice weekly n = 12; current mood month 6, CBT weekly n = 11, CBT twice weekly n = 11 and IPT weekly n = 19; happiness items week 2, CBT twice weekly = 14; happiness items
month 1, IPT weekly n = 13; happiness itemsmonth 3, IPT weekly n = 21 and IPT twice weekly n = 8; happiness itemsmonth 5, IPT weekly n = 24 and IPT twice weekly n = 12; happiness items
month 6, CBT weekly = 11, CBT twice weekly = 10 and IPT weekly = 20; RDQ depressive symptomsmonth 3, IPT weekly n = 21 and IPT twice weekly n = 10; RDQ depressive symptomsmonth
6, IPT twice weekly n = 9; RDQ coping month 3, IPT weekly n = 21; IPT twice weekly n = 10; RDQ other symptoms month 3, IPT weekly n = 21 and IPT twice weekly n = 10; RDQ positive health
month 3, IPT weekly n = 21 and IPT twiceweekly n = 10; RDQ functioningmonth 3, IPT weekly n = 21 and IPT twice weekly n = 11; RDQ life satisfactionmonth 3, IPT weekly n = 22 and IPT twice
weekly n = 10; RDQ well-being month 3, IPT weekly n = 21 and IPT twice weekly n = 10.













Fig. 2 Estimated means on the Beck Depression Inventory-II (BDI-II) per condition over time.
Note that for illustrative purposes the y-axis starts at BDI-II = 15. Note that BDI-II scores at baseline present the observed mean BDI-II score for all conditions at baseline. The x-axis
presents the moment of measurement: baseline, before session 1, and 2 weeks and 1–6 months after the first session. Error bars present the estimated standard error (except for
the baseline values that show the observed standard errors).
CBT, cognitive–behavioural therapy; IPT, interpersonal psychotherapy.
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estimated mean difference at month 6, 2.45) and RDQ positive
health (twice weekly session estimated mean difference at month
6, 1.49; IPT estimated mean difference at month 6, 1.25). There
were no differences between frequencies or treatments on change
over time on the other secondary outcomes. Model descriptions
can be found in Data Supplement 6. Corrected mixed-model esti-
mated means (95% confidence intervals) on all outcome measures
at each time point for each condition are displayed in Data
Supplement 4.
Reliable change and clinically significant change
At month 6, 44.4% (CBT) and 32.3% (IPT) of the patients showed
reliable change in the weekly conditions, whereas 60% (CBT) and
52.9% (IPT) of the patients showed reliable change in the twice
weekly conditions (χ2 = 4.27, P = 0.039). At month 6, 21.6% (CBT)
and 17.6% (IPT) of the patients showed clinically significant
change in the weekly conditions, whereas 25.7% (CBT) and 33.3%
(IPT) of the patients showed clinically significant change in the
twice weekly conditions (χ2 = 1.94, P = 0.16). Reliable and clinically
significant change rates are presented in Data Supplements 7 and 8.
Time to response and remission
There was a significant difference between frequency conditions in
time to response, in favour of twice weekly sessions (hazard ratio
1.48, 95% CI 1.00–2.18, P = 0.049), when controlling for treatment
modality and BDI-II baseline scores. There was no significant differ-
ence between session frequencies in time to remission (hazard ratio
1.22, 95% CI 0.68–2.18, P = 0.49).
Discussion
To our knowledge, this was the first randomised trial to investigate
the effects of once weekly versus twice weekly sessions of CBT and
IPT in patients with depression. We found that twice weekly ses-
sions lead to a greater reduction in depressed symptoms, less time
to response and lower attrition compared with weekly sessions.
The effect of session frequency did not differ between CBT and
IPT and there was no significant difference between frequency con-
ditions in time to remission.
The finding that only a small proportion of the patients in the
present study showed clinically significant change (17.6–33.3%)
and most patients still showed moderate levels of depression post-
treatment contrasts the findings of three other recent, randomised
CBT-IPT studies for depression that report end scores of minimal
to mild levels of depression13,24,25 and higher rates of clinically sig-
nificant change.13 However, our findings are in line with a fourth
CBT-IPT trial26 that also reported moderate post-treatment levels
of depression. This latter study was similar to ours in that they
also included a large number of therapists, whereas the trials that
report lower levels of depression post-treatment had less variation
in settings and therapists, and provided extensive on-site supervi-
sion.13,24,25 One explanation for our findings might be that the
large variation in therapists and treatment settings resulted in sub-
optimal levels of treatment quality and subsequent high average
levels of depression and low clinically significant change at the
end of treatment.
A major strength of the present study is its external validity.
Although the present study has certain characteristics of an efficacy
study, the participation of multiple treatment centres and a large
number of therapists with varying educational backgrounds (i.e.
from less than a year of experience to 29 years of experience) was
necessary to reach the inclusion rate of 200 patients. Therefore,
the present study can best be qualified as an ‘effectiveness’ trial
that generalises to clinical practices outside academic research set-
tings. Moreover, because the quality of the delivered treatments in
the present study was only moderate on average, the effects of
session frequency might be even larger in therapy settings with a
higher level of treatment quality. Another strength of the study is
the fine-grained assessment of session frequency: because patients
completed online questionnaires before each session, we were able
to record the exact difference in session frequency. In addition,
although the implementation of a higher session frequency is a
challenge that will require an organisational change, the finding
that the delivery of twice weekly sessions was entirely possible in
this effectiveness trial is a promising finding in regard to future
implementation.
Several limitations should be considered. First, the ‘pure’ effect
of frequency may have been confounded by the difference in treat-
ment duration (i.e. total time being in therapy) between the fre-
quency conditions. However, this difference was deliberate in the
design of this trial, and relates to cost-effectiveness (to be reported
in a follow-up paper), i.e. the assumption that more frequent ses-
sions leads to less indirect costs (i.e. a reduction of work-days
lost). Second, there were only a few patients with a low educational
background and the number of patients with recurrent depression
was low compared with earlier randomised controlled trials.2,5
These groups should therefore be considered as underrepresented
in the present study. Third, the more frequent assessment of BDI-
II at the beginning of each session might have contributed to the
lower scores in the twice weekly condition, as two preliminary
studies suggest that more frequent BDI assessments can lead to
lower BDI-II scores.27,28 However, such an effect could have only
have occurred in the first 3 months and would have disappeared
in the last 3 months, when BDI-II assessments in the twice weekly
condition were no longer more frequent and equalled out with
the total number of BDI-II assessments in the weekly condition.
Fourth, the present study was not powered to detect small effects
or a difference between the four treatment conditions. The lack of
an interaction between session frequency and treatment modality
should therefore be considered as a preliminary result. Fifth, all
outcome measures were self-reported and the clinical status of the
participants at post-treatment could not be confirmed in the
absence of an observer-rated outcome measure. Sixth, no psycho-
metric properties are available for the IPT-AQS yet, and therefore
conclusions about the quality of IPT should be considered
preliminary.
In summary, the present study demonstrates that in clinical
practice settings both CBT and IPT are best provided twice
weekly. This finding implies that reorganisation of the specialised
mental healthcare services for depression (going from once a
week to twice a week) can lead to less attrition, quicker response
and better outcomes across the course of treatment.
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